Abp-788.mp4 Apr 2026

: Uses a highly stable oxime bond to prevent the premature release of the toxin into the bloodstream, which reduces systemic side effects.

If the video discusses trial results, it likely highlights these key areas: ABP-788.mp4

The "guide" in the video likely explains the : : Uses a highly stable oxime bond to

: In the ACE-Breast-02 trial , ARX788 significantly improved progression-free survival (PFS) to 11.3 months compared to 8.2 months for standard treatments. ABP-788.mp4